CDC45
Basic information
Region (hg38): 22:19479457-19520612
Previous symbols: [ "CDC45L2", "CDC45L" ]
Links
Phenotypes
GenCC
Source:
- Meier-Gorlin syndrome 7 (Strong), mode of inheritance: AR
- Meier-Gorlin syndrome 7 (Strong), mode of inheritance: AR
- Meier-Gorlin syndrome (Supportive), mode of inheritance: AD
- Meier-Gorlin syndrome 7 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Meier-Gorlin syndrome 7 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Gastrointestinal; Musculoskeletal; Neurologic | 27374770 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (8 variants)
- Meier-Gorlin syndrome 7 (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDC45 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 37 | 46 | ||||
missense | 81 | 93 | ||||
nonsense | 3 | |||||
start loss | 1 | |||||
frameshift | 7 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 6 | 15 | 1 | 23 | |
non coding | 61 | 29 | 98 | |||
Total | 9 | 7 | 93 | 104 | 36 |
Variants in CDC45
This is a list of pathogenic ClinVar variants found in the CDC45 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-19479706-T-G | Likely benign (Apr 20, 2019) | |||
22-19479774-C-G | Benign (Nov 10, 2018) | |||
22-19479837-G-A | Likely benign (Mar 31, 2019) | |||
22-19479939-G-T | Benign (Oct 31, 2018) | |||
22-19479969-A-C | Uncertain significance (Nov 28, 2022) | |||
22-19479972-T-A | Uncertain significance (Jul 12, 2022) | |||
22-19479980-C-A | Uncertain significance (Jun 01, 2021) | |||
22-19479987-C-G | Conflicting classifications of pathogenicity (Jan 08, 2024) | |||
22-19479992-A-G | Likely benign (Jun 24, 2022) | |||
22-19480009-T-C | Inborn genetic diseases | Uncertain significance (Dec 13, 2022) | ||
22-19480024-C-T | Uncertain significance (May 04, 2022) | |||
22-19480027-C-T | Likely benign (Apr 25, 2021) | |||
22-19480030-G-A | Likely benign (Aug 23, 2022) | |||
22-19480129-T-C | Benign (Oct 16, 2018) | |||
22-19480146-C-T | Likely benign (Jun 05, 2023) | |||
22-19480152-C-T | Likely benign (Sep 08, 2020) | |||
22-19480153-G-T | Likely benign (Sep 03, 2021) | |||
22-19480156-A-G | Likely pathogenic (Mar 18, 2022) | |||
22-19480194-C-T | Benign (Jan 29, 2024) | |||
22-19480364-G-A | Likely benign (Dec 01, 2018) | |||
22-19480414-G-A | Benign (Mar 01, 2020) | |||
22-19480495-AG-A | Likely benign (Aug 05, 2019) | |||
22-19480848-C-T | Likely benign (Mar 16, 2019) | |||
22-19480940-ACT-A | Likely benign (Mar 29, 2023) | |||
22-19480944-T-C | Uncertain significance (Apr 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDC45 | protein_coding | protein_coding | ENST00000437685 | 19 | 41154 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000462 | 1.00 | 125703 | 0 | 45 | 125748 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.828 | 315 | 359 | 0.877 | 0.0000210 | 3991 |
Missense in Polyphen | 67 | 94.977 | 0.70544 | 1014 | ||
Synonymous | 0.729 | 129 | 140 | 0.922 | 0.00000846 | 1091 |
Loss of Function | 3.46 | 14 | 36.6 | 0.383 | 0.00000173 | 410 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000763 | 0.000761 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000159 | 0.000158 |
Middle Eastern | 0.000763 | 0.000761 |
South Asian | 0.000261 | 0.000261 |
Other | 0.000339 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Required for initiation of chromosomal DNA replication.;
- Pathway
- Cell cycle - Homo sapiens (human);Cell Cycle;Mitotic G1-G1-S phases;Retinoblastoma (RB) in Cancer;G1 to S cell cycle control;DNA Replication;Activation of ATR in response to replication stress;G2/M Checkpoints;Cell Cycle Checkpoints;Activation of E2F1 target genes at G1/S;G1/S-Specific Transcription;Activation of the pre-replicative complex;Unwinding of DNA;Mitotic G1-G1/S phases;DNA Replication;DNA strand elongation;Synthesis of DNA;S Phase;G1/S Transition;DNA Replication Pre-Initiation;M/G1 Transition;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.236
Intolerance Scores
- loftool
- rvis_EVS
- -0.27
- rvis_percentile_EVS
- 34.82
Haploinsufficiency Scores
- pHI
- 0.986
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.649
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdc45
- Phenotype
- embryo phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cellular phenotype;
Gene ontology
- Biological process
- DNA replication checkpoint;G1/S transition of mitotic cell cycle;regulation of transcription involved in G1/S transition of mitotic cell cycle;double-strand break repair via break-induced replication;DNA replication;DNA replication initiation;regulation of chromatin silencing at telomere;DNA duplex unwinding;positive regulation of G1/S transition of mitotic cell cycle;mitotic DNA replication preinitiation complex assembly
- Cellular component
- nucleus;nucleoplasm;nuclear pre-replicative complex;cytoplasm;centrosome;DNA replication preinitiation complex;replication fork protection complex
- Molecular function
- chromatin binding;DNA replication origin binding;single-stranded DNA binding;protein binding;3'-5' DNA helicase activity